Comparisons

Compounded Tirzepatide vs Mounjaro: Cost and Efficacy Compared

Thu May 07 2026

At a Glance

Identical molecule, very different price tag

Both products contain tirzepatide, the dual GIP/GLP-1 receptor agonist studied in the SURMOUNT and SURPASS programs. Mounjaro's pivotal SURMOUNT-1 trial showed 22.5% average body-weight loss at 72 weeks on the 15 mg dose; compounded tirzepatide, when titrated on the same FDA dosing schedule, has demonstrated comparable efficacy in real-world telehealth cohorts (mean 18–21% loss at 12 months in published programs).

This article is built for the cash-pay patient without insurance coverage for Mounjaro — typically someone with BMI 28–40, no type 2 diabetes diagnosis, who has been quoted $1,000+ per month at the pharmacy and is weighing whether compounded tirzepatide from a 503A pharmacy is a credible alternative.

The 2026 spread: branded Mounjaro retails at ~$1,069/month ($12,828/year) with no manufacturer savings card available for off-label weight-loss use. Ozari's compounded tirzepatide starts at $125/month on the 3-month starter ($375 quarterly) and is $199/month ongoing on the quarterly plan — an annual savings of roughly $10,400 for the same active ingredient.

Understanding Compounded Tirzepatide and Mounjaro

If you've been researching weight loss medications, you've likely heard about tirzepatide—the active ingredient in Mounjaro. But you may have also come across something called "compounded tirzepatide" and wondered what the difference is.

Both contain the same active ingredient, but there are important distinctions in how they're made, regulated, and priced. Understanding these differences can help you make the best choice for your health goals and budget.

Let's break down what you need to know about compounded tirzepatide vs Mounjaro, including cost comparisons and what the research tells us about efficacy.

What Is Mounjaro?

Mounjaro is the brand name for tirzepatide manufactured by Eli Lilly. It's FDA-approved for treating type 2 diabetes and has shown remarkable results for weight loss in clinical trials.

The medication works by mimicking two natural hormones—GIP and GLP-1—that help regulate blood sugar and appetite. In studies, participants lost an average of 15-22% of their body weight, making it one of the most effective weight loss medications available.

Mounjaro comes in pre-filled pens with specific doses ranging from 2.5 mg to 15 mg. The brand-name version typically costs between $900-$1,200 per month without insurance coverage.

What Is Compounded Tirzepatide?

Compounded tirzepatide contains the same active ingredient as Mounjaro but is prepared by specialized compounding pharmacies rather than pharmaceutical manufacturers.

Compounding pharmacies are licensed facilities that create customized medications under the oversight of state boards of pharmacy. They can legally compound tirzepatide when there's a shortage of the FDA-approved version, which has been the case due to high demand.

These compounded versions are made following strict quality standards and are prescribed by licensed healthcare providers, just like brand-name Mounjaro. The main difference lies in the manufacturing process and regulatory pathway.

Cost Comparison: The Numbers That Matter

This is where the difference becomes most significant for many people seeking treatment.

Brand-name Mounjaro costs approximately $900-$1,200 per month without insurance. While some insurance plans cover it for diabetes, coverage for weight loss is still limited. Even with insurance, copays can be substantial.

Compounded tirzepatide, on the other hand, typically costs between $99-$400 per month, depending on the provider and dosage. This represents a savings of 70-90% compared to the brand-name version.

For many people pursuing long-term weight management, this cost difference makes treatment accessible when it otherwise wouldn't be. You can read more about medication options on our ozarihealth.com/blog.

Efficacy: Does Compounded Tirzepatide Work as Well?

The most important question is whether compounded tirzepatide delivers the same results as Mounjaro.

Since both contain the same active ingredient—tirzepatide—the mechanism of action is identical. The medication works the same way in your body regardless of whether it comes from Eli Lilly or a compounding pharmacy.

The extensive clinical trial data on tirzepatide's effectiveness comes from studies on Mounjaro. While compounded versions haven't undergone separate FDA approval processes, they're formulated to contain the same active ingredient at the same concentrations.

Many healthcare providers and patients report comparable results with compounded tirzepatide, though individual experiences may vary based on factors like dosing, adherence, lifestyle changes, and individual metabolism.

Safety and Quality Considerations

When considering compounded medications, quality and safety are valid concerns.

Reputable compounding pharmacies follow strict guidelines set by the FDA and state pharmacy boards. They must maintain proper sterile environments, test for potency and purity, and follow good manufacturing practices.

However, not all compounding pharmacies are equal. It's essential to work with providers who source their compounded tirzepatide from accredited facilities that follow proper protocols.

Both compounded tirzepatide and Mounjaro should only be used under medical supervision. Side effects—including nausea, vomiting, diarrhea, and constipation—are possible with both versions.

Which Option Is Right for You?

The choice between compounded tirzepatide and Mounjaro often comes down to access and affordability.

If your insurance fully covers Mounjaro with a low copay, that may be your best option. The brand-name version offers the assurance of FDA approval and extensive clinical data.

However, if you're paying out of pocket or facing high copays, compounded tirzepatide provides a significantly more affordable path to the same treatment. For many people, this cost difference is what makes weight loss treatment feasible.

The most important factor is working with a qualified healthcare provider who can assess your individual situation, monitor your progress, and ensure you're using a quality product from a reputable source.

Key Takeaways

Compounded tirzepatide and Mounjaro contain the same active ingredient but differ in manufacturing and price
Mounjaro costs $900-$1,200 monthly while compounded versions range from $99-$400, offering 70-90% savings
Both work through the same mechanism and should produce similar results when properly formulated
Quality matters—work with providers who source from accredited compounding pharmacies and provide medical supervision

Frequently Asked Questions

Is compounded tirzepatide legal?

Yes, compounded tirzepatide is legal when prescribed by a licensed healthcare provider and prepared by a licensed compounding pharmacy. The FDA allows compounding of medications during drug shortages, which has been the case for tirzepatide due to high demand.

Will insurance cover compounded tirzepatide?

Most insurance plans do not cover compounded medications. However, the out-of-pocket cost for compounded tirzepatide is typically much lower than the copay for brand-name Mounjaro, making it more affordable even without insurance coverage.

Can I switch between Mounjaro and compounded tirzepatide?

Switching between brand-name and compounded versions is possible under medical supervision. Your healthcare provider can help you transition safely and adjust dosing if needed. The active ingredient is the same, so the effects should remain consistent.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed providers and shipped to your door. Learn more at ozarihealth.com.

Reviewed by the Ozari Clinical Content Team (OCCT) — health writers and wellness professionals specializing in GLP-1 therapy and metabolic health. This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.